Onward Medical N.V. (EBR:ONWD)

Belgium flag Belgium · Delayed Price · Currency is EUR
4.200
+0.100 (2.44%)
At close: Feb 27, 2026
-25.27%
Market Cap 235.24M
Revenue (ttm) 2.72M
Net Income (ttm) -38.65M
Shares Out 56.01M
EPS (ttm) -0.78
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 189,542
Average Volume 82,988
Open 4.100
Previous Close 4.100
Day's Range 4.055 - 4.200
52-Week Range 3.495 - 5.770
Beta 0.91
RSI 49.50
Earnings Date Mar 31, 2026

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement. It operates in France, Germany, the Netherlands, the United Ki... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 103
Stock Exchange Euronext Brussels
Ticker Symbol ONWD
Full Company Profile

Financial Performance

In 2024, Onward Medical's revenue was 1.74 million, an increase of 226.88% compared to the previous year's 532,000. Losses were -35.73 million, -1.26% less than in 2023.

Financial Statements

News

There is no news available yet.